Arbutus Biopharma Corporation (NASDAQ: ABUS) today announced that James Meyers and Myrtle Potter have been appointed to the Arbutus Board ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE